328 results on '"Drug approval -- Technology application"'
Search Results
2. Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA 'de novo' approval
3. Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA 'de novo' approval
4. BASF: Chinaplas 2024 - The next generation - robust and colorful baby bottles
5. Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO(r)|DARZALEX(r) (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma
6. Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO(r)|DARZALEX(r) as subcutaneous monotherapy for high-risk smoldering multiple myeloma
7. Odine Participates in TAoeBA[degree sign]TAK-Approved R&D Project
8. Odine Participates in TAoeBA[degree sign]TAK-Approved R&D Project
9. Sleep Specialists and Industry Leaders Converge at HoneyNaps Symposium
10. AI Meets Regulation: Element's RegNav Revolutionizes Medical Device Compliance
11. 'Dialkyl Tryptamines And Their Therapeutic Uses' in Patent Application Approval Process (USPTO 20230346747)
12. DeepTek's AI-powered chest X-ray screening solution, Genki gets Thai FDA approval
13. German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications
14. Navigating Health Tech: Regulations For AI/ML In Medical Devices And Software (Video)
15. Investigators from Linkoping University Have Reported New Data on Chronic Pain (Electrophoretic Delivery of Clinically Approved Anesthetic Drug for Chronic Pain Therapy)
16. Inhibition of sensory neuron driven acute, inflammatory, and neuropathic pain using a humanised chemogenetic system
17. Lumicell Announces FDA Advisory Committee's Positive Recommendation on the Benefit-Risk Profile of LUMISIGHT[TM] in the Detection of Cancerous Tissue During Breast Conserving Surgery
18. Finland is applying for more than 81 million euros in EU funding for five digital initiatives
19. FDA/CDRH's Take On The Growing Importance Of Transparency In AI/ML-Enabled Medical Devices
20. ProLynx Announces a Publication Proposing that a Long-Acting Prodrug of SN-38 Could be Effective in Treating Sacituzumab Govitecan-Resistant Tumors
21. ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors
22. ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors
23. Halozyme Announces Takeda Receives FDA Approval for HYQVIA(r) Co-formulated with ENHANZE(r) as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
24. Halozyme Announces Takeda Receives FDA Approval for HYQVIA Co-formulated with ENHANZE as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
25. Concerto Biosciences' Ensemble No.2 (ENS-002) IND application receives US FDA approval
26. Concerto Biosciences' Ensemble No.2 (ENS-002) IND application receives US FDA approval
27. Protein Coronas Derived from Cerebrospinal Fluid Enhance the Interactions Between Nanoparticles and Brain Cells
28. SetPoint: First Patient Enrolled in Stage 2 of Pivotal Study of Medical's Pioneering Technology for the Treatment of Rheumatoid Arthritis
29. Gamida Cell says FDA accepts biologics license application for for omidubicel
30. Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
31. Terran Biosciences Receives Notice of Allowance for Four US Patents Including for the World's First New Salts
32. RetinalGeniXtm Technologies files two provisional patent applications
33. RetinalGeniX(TM) Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
34. Alucent Biomedical Receive Regulatory Approval for Second U.S. Clinical Study
35. The FDA has granted approval to GE HealthCare for Allia IGS Pulse, the latest iteration of image-guided systems tailored for superior cardiac imaging
36. Good news: The 'Second Scorching Heat List' list was released, and Bangyao Biotechnology won the title of 'Scorching Star Enterprise'!
37. CARBIOS Active approved by FDA for food contact applications
38. Levena Biopharma announces clinical data for A166 in breast cancer
39. Scottsdale's Aesthetic IQ Clinic Offers Breakthrough Undereye Treatment, Restylane Eyelight
40. CSPC Pharmaceutical Group's GLP-1 target drug project is approved as a major scientific and technological innovation project
41. SimonMed Imaging Implements 3rd Generation iCAD Breast AI 3.0
42. GALDERMA RECEIVES FDA APPROVAL FOR ITS NEWEST HYALURONIC ACID FILLER, RESTYLANE EYELIGHT
43. Investigators at Cancer Biology Laboratory Describe Findings in Bioorganic Chemistry (Chemistry of Oxadiazole Analogues: Current Status and Applications)
44. Xenex Makes De Novo Petition to FDA for LightStrike UV Room Disinfection Technology
45. Xenex Makes De Novo Petition to FDA for LightStrike UV Room Disinfection Technology
46. US FDA grants priority review status for Merck & Eisai's Keytruda plus Lenvima applications for advanced RCC and advanced endometrial carcinoma
47. AbbVie submits regulatory applications for SKYRIZI to FDA, EMA
48. Merck seeks US FDA & European approvals for investigational 15-valent pneumococcal conjugate vaccine, V114 for use in adults
49. AbbVie submits regulatory applications to FDA, EMA for RINVOQ
50. Tech execs are donating millions to make MDMA a legal treatment for PTSD, continuing Silicon Valley's longtime love-affair with psychedelics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.